Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Jul;62(7):2800–2805. doi: 10.1128/iai.62.7.2800-2805.1994

Affinity of the C9 molecule for the C5b-8 complex compared with that for the complex containing C9 molecules.

S L MacKay 1, J R Dankert 1
PMCID: PMC302884  PMID: 8005670

Abstract

Gram-negative bacterial cells exposed to a complement source may carry membrane attack complexes containing variable numbers of C9 molecules per C5b-8 site. In order to investigate the assembly of this complex, the ability of C9 molecules to bind to C5b-8 complexes was compared with the binding characteristics of C9 for C5b-8 complexes containing variable numbers of bound C9 molecules. The apparent dissociation constant (Kd) of the C9 molecule for the C5b-8 site on a complement-sensitive strain of Escherichia coli was 1.2 (+/- 0.15) nM at 0 degree C. These conditions allow the binding of one C9 molecule per C5b-8 site. The C5b-8 site containing one C9 molecule bound a second C9 molecule at 0 degree C only after incubation at 37 degrees C. The binding of C9 to a C5b-8 site containing one C9 molecule was found to be 1.3 (+/- 0.2) nM. Therefore, the presence of a C9 molecule did not significantly alter the binding capacity of the C5b-8 site for additional C9 molecules. A similar result was obtained by using rabbit erythrocytes bearing either C5b-8 sites or C5b-8 sites containing one molecule of C9 per complex at 0 degree C. The similarity of binding characteristics for the first and second C9 molecules argues that the initial C9 molecule in the complex does not affect the binding of subsequent C9 molecules. This suggests that a unique C9 binding site that does not involve previously bound C9 molecules may exist on the forming membrane attack complex.

Full text

PDF
2800

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azimzadeh A., Weiss E., Van Regenmortel M. H. Measurement of affinity of viral monoclonal antibodies using Fab'-peroxidase conjugate. Influence of antibody concentration on apparent affinity. Mol Immunol. 1992 May;29(5):601–608. doi: 10.1016/0161-5890(92)90196-5. [DOI] [PubMed] [Google Scholar]
  2. Bhakdi S., Ey P., Bhakdi-Lehnen B. Isolation of the terminal complement complex from target sheep erythrocyte membranes. Biochim Biophys Acta. 1976 Feb 6;419(3):445–457. doi: 10.1016/0005-2736(76)90258-3. [DOI] [PubMed] [Google Scholar]
  3. Bhakdi S., Kuller G., Muhly M., Fromm S., Seibert G., Parrisius J. Formation of transmural complement pores in serum-sensitive Escherichia coli. Infect Immun. 1987 Jan;55(1):206–210. doi: 10.1128/iai.55.1.206-210.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bhakdi S., Tranum-Jensen J. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore. J Immunol. 1986 Apr 15;136(8):2999–3005. [PubMed] [Google Scholar]
  5. Bhakdi S., Tranum-Jensen J. Complement lysis: a hole is a hole. Immunol Today. 1991 Sep;12(9):318–321. doi: 10.1016/0167-5699(91)90007-G. [DOI] [PubMed] [Google Scholar]
  6. Biesecker G., Lachmann P., Henderson R. Structure of complement poly-C9 determined in projection by cryo-electron microscopy and single particle analysis. Mol Immunol. 1993 Oct;30(15):1369–1382. doi: 10.1016/0161-5890(93)90098-v. [DOI] [PubMed] [Google Scholar]
  7. Bliska J. B., Falkow S. Bacterial resistance to complement killing mediated by the Ail protein of Yersinia enterocolitica. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3561–3565. doi: 10.1073/pnas.89.8.3561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boyle M. D., Langone J. J., Borsos T. Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel. J Immunol. 1978 May;120(5):1721–1725. [PubMed] [Google Scholar]
  9. Dankert J. R. Complement-mediated inhibition of function in complement-resistant Escherichia coli. J Immunol. 1989 Mar 1;142(5):1591–1595. [PubMed] [Google Scholar]
  10. Dankert J. R., Esser A. F. Complement-mediated killing of Escherichia coli: dissipation of membrane potential by a C9-derived peptide. Biochemistry. 1986 Mar 11;25(5):1094–1100. doi: 10.1021/bi00353a023. [DOI] [PubMed] [Google Scholar]
  11. Dankert J. R., Shiver J. W., Esser A. F. Ninth component of complement: self-aggregation and interaction with lipids. Biochemistry. 1985 May 21;24(11):2754–2762. doi: 10.1021/bi00332a024. [DOI] [PubMed] [Google Scholar]
  12. DiScipio R. G. The relationship between polymerization of complement component C9 and membrane channel formation. J Immunol. 1991 Dec 15;147(12):4239–4247. [PubMed] [Google Scholar]
  13. Esser A. F. Big MAC attack: complement proteins cause leaky patches. Immunol Today. 1991 Sep;12(9):316–321. doi: 10.1016/0167-5699(91)90006-F. [DOI] [PubMed] [Google Scholar]
  14. Esser A. F. The membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicology. 1994 Feb 28;87(1-3):229–247. doi: 10.1016/0300-483x(94)90253-4. [DOI] [PubMed] [Google Scholar]
  15. Frankel M. E., Gerhard W. The rapid determination of binding constants for antiviral antibodies by a radioimmunoassay. An analysis of the interaction between hybridoma proteins and influenza virus. Mol Immunol. 1979 Feb;16(2):101–106. doi: 10.1016/0161-5890(79)90051-8. [DOI] [PubMed] [Google Scholar]
  16. Hu V. W., Esser A. F., Podack E. R., Wisnieski B. J. The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane. J Immunol. 1981 Jul;127(1):380–386. [PubMed] [Google Scholar]
  17. Ishida B., Wisnieski B. J., Lavine C. H., Esser A. F. Photolabeling of a hydrophobic domain of the ninth component of human complement. J Biol Chem. 1982 Sep 25;257(18):10551–10553. [PubMed] [Google Scholar]
  18. Joiner K. A., Brown E. J., Frank M. M. Complement and bacteria: chemistry and biology in host defense. Annu Rev Immunol. 1984;2:461–491. doi: 10.1146/annurev.iy.02.040184.002333. [DOI] [PubMed] [Google Scholar]
  19. Joiner K. A., Schmetz M. A., Sanders M. E., Murray T. G., Hammer C. H., Dourmashkin R., Frank M. M. Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. Proc Natl Acad Sci U S A. 1985 Jul;82(14):4808–4812. doi: 10.1073/pnas.82.14.4808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kolb W. P., Muller-Eberhard H. J. The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex. J Exp Med. 1975 Apr 1;141(4):724–735. [PMC free article] [PubMed] [Google Scholar]
  21. Lachmann P. J. The control of homologous lysis. Immunol Today. 1991 Sep;12(9):312–315. doi: 10.1016/0167-5699(91)90005-E. [DOI] [PubMed] [Google Scholar]
  22. Laine R. O., Esser A. F. Detection of refolding conformers of complement protein C9 during insertion into membranes. Nature. 1989 Sep 7;341(6237):63–65. doi: 10.1038/341063a0. [DOI] [PubMed] [Google Scholar]
  23. MacKay S. L., Dankert J. R. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites. J Immunol. 1990 Nov 15;145(10):3367–3371. [PubMed] [Google Scholar]
  24. Marazziti D., Luzio J. P., Stanley K. K. Complement C9 is inserted into membranes in a globular conformation. FEBS Lett. 1989 Jan 30;243(2):347–350. doi: 10.1016/0014-5793(89)80159-0. [DOI] [PubMed] [Google Scholar]
  25. Martinez R. J., Carroll S. F. Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme. Infect Immun. 1980 Jun;28(3):735–745. doi: 10.1128/iai.28.3.735-745.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Meri S., Morgan B. P., Davies A., Daniels R. H., Olavesen M. G., Waldmann H., Lachmann P. J. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology. 1990 Sep;71(1):1–9. [PMC free article] [PubMed] [Google Scholar]
  27. Podack E. R., Biesecker G., Kolb W. P., Müller-Eberhard H. J. The C5b-6 complex: reaction with C7, C8, C9. J Immunol. 1978 Aug;121(2):484–490. [PubMed] [Google Scholar]
  28. Podack E. R., Tschopp J. Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement. Proc Natl Acad Sci U S A. 1982 Jan;79(2):574–578. doi: 10.1073/pnas.79.2.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pramoonjago P., Kaneko M., Kinoshita T., Ohtsubo E., Takeda J., Hong K. S., Inagi R., Inoue K. Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance. J Immunol. 1992 Feb 1;148(3):827–836. [PubMed] [Google Scholar]
  30. Rollins S. A., Sims P. J. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol. 1990 May 1;144(9):3478–3483. [PubMed] [Google Scholar]
  31. Shiver J. W., Dankert J. R., Donovan J. J., Esser A. F. The ninth component of human complement (C9). Functional activity of the b fragment. J Biol Chem. 1986 Jul 25;261(21):9629–9636. [PubMed] [Google Scholar]
  32. Steckel E. W., Welbaum B. E., Sodetz J. M. Evidence of direct insertion of terminal complement proteins into cell membrane bilayers during cytolysis. Labeling by a photosensitive membrane probe reveals a major role for the eighth and ninth components. J Biol Chem. 1983 Apr 10;258(7):4318–4324. [PubMed] [Google Scholar]
  33. Steckel E. W., York R. G., Monahan J. B., Sodetz J. M. The eighth component of human complement. Purification and physicochemical characterization of its unusual subunit structure. J Biol Chem. 1980 Dec 25;255(24):11997–12005. [PubMed] [Google Scholar]
  34. Taylor P. W. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev. 1983 Mar;47(1):46–83. doi: 10.1128/mr.47.1.46-83.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Taylor P. W., Kroll H. P. Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli. Mol Immunol. 1984 Jul;21(7):609–620. doi: 10.1016/0161-5890(84)90046-4. [DOI] [PubMed] [Google Scholar]
  36. Tschopp J. Circular polymerization of the membranolytic ninth component of complement. Dependence on metal ions. J Biol Chem. 1984 Aug 25;259(16):10569–10573. [PubMed] [Google Scholar]
  37. Tschopp J., Podack E. R. Membranolysis by the ninth component of human complement. Biochem Biophys Res Commun. 1981 Jun 16;100(3):1409–1414. doi: 10.1016/0006-291x(81)91981-1. [DOI] [PubMed] [Google Scholar]
  38. Verduin C. M., Jansze M., Hol C., Mollnes T. E., Verhoef J., van Dijk H. Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation. Infect Immun. 1994 Feb;62(2):589–595. doi: 10.1128/iai.62.2.589-595.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES